Peter M. Pushko

Person

Rockville, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Adjuvanted vaccines containing modified S1 Spike protein of SARS-Co...
- Patent number 11,911,461
- Issue date Feb 27, 2024
- D4 Labs, LLC
- David Craig Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant bovine immunodeficiency virus gag virus-like particles...
- Patent number 11,576,965
- Issue date Feb 14, 2023
- Medigen, Inc.
- Peter Pushko
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 11,446,374
- Issue date Sep 20, 2022
- Novavax, Inc.
- Peter M. Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccines against infectious diseases caused by positive stranded RN...
- Patent number 11,058,759
- Issue date Jul 13, 2021
- Medigen, Inc.
- Peter Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 11,052,146
- Issue date Jul 6, 2021
- Novavax, Inc.
- Peter M. Pushko
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Functional influenza virus like particles (VLPs)
- Patent number 10,729,760
- Issue date Aug 4, 2020
- Novavax, Inc.
- Gale Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
iDNA vaccines and methods for using the same
- Patent number 10,653,769
- Issue date May 19, 2020
- Medigen, Inc.
- Peter Pushko
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Functional influenza virus-like particles (VLPS)
- Patent number 10,548,968
- Issue date Feb 4, 2020
- Novavax, Inc.
- Gale Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Highly efficient influenza matrix (M1) proteins
- Patent number 10,544,399
- Issue date Jan 28, 2020
- Novavax, Inc.
- Gale Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Functional influenza virus like particles (VLPs)
- Patent number 10,188,723
- Issue date Jan 29, 2019
- Novavax, Inc.
- Gale Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 10,022,437
- Issue date Jul 17, 2018
- Novavax, Inc.
- Peter Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IDNA vaccines and methods for using the same
- Patent number 9,968,672
- Issue date May 15, 2018
- Medigen, Inc.
- Peter Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus-like particles (VLPs)
- Patent number 9,956,280
- Issue date May 1, 2018
- Novavax, Inc.
- Robin A. Robinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly efficient influenza matrix (M1) proteins
- Patent number 9,951,317
- Issue date Apr 24, 2018
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus-like particles (VLPS)
- Patent number 9,937,253
- Issue date Apr 10, 2018
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 9,731,000
- Issue date Aug 15, 2017
- Novavax, Inc.
- Peter M. Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 9,717,786
- Issue date Aug 1, 2017
- Novavax, Inc.
- Peter M. Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus like particles (VLPs)
- Patent number 9,694,066
- Issue date Jul 4, 2017
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Infectious DNA vaccines against chikungunya virus
- Patent number 9,694,065
- Issue date Jul 4, 2017
- Medigen, Inc.
- Peter Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 9,675,685
- Issue date Jun 13, 2017
- Novavax, Inc.
- Peter Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus-like particles (VLPS)
- Patent number 9,623,104
- Issue date Apr 18, 2017
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus-like particles (VLPS)
- Patent number 9,474,799
- Issue date Oct 25, 2016
- Novavax, Inc.
- Robin A. Robinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly efficient influenza matrix (M1) proteins
- Patent number 9,464,276
- Issue date Oct 11, 2016
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VLPS derived from cells that do not express a viral matrix or core...
- Patent number 9,381,239
- Issue date Jul 5, 2016
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus-like particles (VLPs)
- Patent number 9,180,180
- Issue date Nov 10, 2015
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus-like particles (VLPs)
- Patent number 9,144,607
- Issue date Sep 29, 2015
- Novavax, Inc.
- Robin A. Robinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Infectious DNA vaccines against chikungunya virus
- Patent number 9,101,572
- Issue date Aug 11, 2015
- Medigen, Inc.
- Peter Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus like particles (VLPs)
- Patent number 9,050,290
- Issue date Jun 9, 2015
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly efficient influenza matrix (M1) proteins
- Patent number 8,992,939
- Issue date Mar 31, 2015
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus-like particles (VLPs)
- Patent number 8,951,537
- Issue date Feb 10, 2015
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
DJUVANTED PROTEIN VACCINES COMPRISING MODIFIED FULL-LENGTH SPIKE PR...
- Publication number 20240277832
- Publication date Aug 22, 2024
- D4 Labs, LLC
- David Craig Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT VIRUS LIKE PARTICLES USING BOVINE IMMUNODEFICIENCY VIRU...
- Publication number 20230310579
- Publication date Oct 5, 2023
- MEDIGEN, INC.
- Peter PUSHKO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20230293667
- Publication date Sep 21, 2023
- NOVAVAX, INC.
- Peter M. PUSHKO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RN...
- Publication number 20210322535
- Publication date Oct 21, 2021
- MEDIGEN, INC.
- Peter PUSHKO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20200030436
- Publication date Jan 30, 2020
- NOVAVAX, INC.
- Peter M. PUSHKO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)
- Publication number 20190314484
- Publication date Oct 17, 2019
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RN...
- Publication number 20190314482
- Publication date Oct 17, 2019
- MEDIGEN, INC.
- Peter PUSHKO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20190134187
- Publication date May 9, 2019
- NOVAVAX, INC.
- Peter M. PUSHKO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS
- Publication number 20190062713
- Publication date Feb 28, 2019
- NOVAVAX, INC.
- Gale SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20190038738
- Publication date Feb 7, 2019
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT VIRUS LIKE PARTICLES USING BOVINE IMMUNODEFICIENCY VIRU...
- Publication number 20180369364
- Publication date Dec 27, 2018
- MEDIGEN, INC.
- Peter PUSHKO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IDNA VACCINES AND METHODS FOR USING THE SAME
- Publication number 20180243404
- Publication date Aug 30, 2018
- MEDIGEN, INC.
- Peter Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)
- Publication number 20180110851
- Publication date Apr 26, 2018
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20170252427
- Publication date Sep 7, 2017
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS
- Publication number 20170253861
- Publication date Sep 7, 2017
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20170232095
- Publication date Aug 17, 2017
- NOVAVAX, INC.
- Robin A. ROBINSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INFECTIOUS DNA VACCINES AGAINST CHIKUNGUNYA VIRUS
- Publication number 20160074500
- Publication date Mar 17, 2016
- MEDIGEN, INC.
- Peter Pushko
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20160008456
- Publication date Jan 14, 2016
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)
- Publication number 20150374813
- Publication date Dec 31, 2015
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20150359872
- Publication date Dec 17, 2015
- NOVAVAX, INC.
- Peter PUSHKO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20150306206
- Publication date Oct 29, 2015
- NOVAVAX, INC.
- Robin A. ROBINSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS
- Publication number 20150307849
- Publication date Oct 29, 2015
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20150266930
- Publication date Sep 24, 2015
- NOVAVAX, INC.
- Peter PUSHKO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20150265698
- Publication date Sep 24, 2015
- NOVAVAX, INC.
- Peter PUSHKO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20140294879
- Publication date Oct 2, 2014
- NOVAVAX, INC.
- Peter PUSHKO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL VLPS DERIVED FROM CELLS THAT DO NOT EXPRESS A VIRAL MATRIX OR...
- Publication number 20140234372
- Publication date Aug 21, 2014
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20140193447
- Publication date Jul 10, 2014
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IDNA VACCINES AND METHODS FOR USING THE SAME
- Publication number 20140178430
- Publication date Jun 26, 2014
- Peter PUSHKO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)
- Publication number 20130295135
- Publication date Nov 7, 2013
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20130177587
- Publication date Jul 11, 2013
- NOVAVAX, INC.
- Robin A. ROBINSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Peter M. Pushko

Person

Patents Grantslast 30 patents

Adjuvanted vaccines containing modified S1 Spike protein of SARS-Co...

Recombinant bovine immunodeficiency virus gag virus-like particles...

Modified RSV F proteins and methods of their use

Vaccines against infectious diseases caused by positive stranded RN...

Modified RSV F proteins and methods of their use

Functional influenza virus like particles (VLPs)

iDNA vaccines and methods for using the same

Functional influenza virus-like particles (VLPS)

Highly efficient influenza matrix (M1) proteins

Functional influenza virus like particles (VLPs)

Modified RSV F proteins and methods of their use

IDNA vaccines and methods for using the same

Functional influenza virus-like particles (VLPs)

Highly efficient influenza matrix (M1) proteins

Functional influenza virus-like particles (VLPS)

Modified RSV F proteins and methods of their use

Modified RSV F proteins and methods of their use

Functional influenza virus like particles (VLPs)

Infectious DNA vaccines against chikungunya virus

Modified RSV F proteins and methods of their use

Functional influenza virus-like particles (VLPS)

Functional influenza virus-like particles (VLPS)

Highly efficient influenza matrix (M1) proteins

VLPS derived from cells that do not express a viral matrix or core...

Functional influenza virus-like particles (VLPs)

Functional influenza virus-like particles (VLPs)

Infectious DNA vaccines against chikungunya virus

Functional influenza virus like particles (VLPs)

Highly efficient influenza matrix (M1) proteins

Functional influenza virus-like particles (VLPs)

Patents Applicationslast 30 patents

DJUVANTED PROTEIN VACCINES COMPRISING MODIFIED FULL-LENGTH SPIKE PR...

RECOMBINANT VIRUS LIKE PARTICLES USING BOVINE IMMUNODEFICIENCY VIRU...

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RN...

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)

VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RN...

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS

FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

RECOMBINANT VIRUS LIKE PARTICLES USING BOVINE IMMUNODEFICIENCY VIRU...

IDNA VACCINES AND METHODS FOR USING THE SAME

FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)

FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS

FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

INFECTIOUS DNA VACCINES AGAINST CHIKUNGUNYA VIRUS

FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

NOVEL VLPS DERIVED FROM CELLS THAT DO NOT EXPRESS A VIRAL MATRIX OR...

FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

IDNA VACCINES AND METHODS FOR USING THE SAME

FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)

FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)